177 related articles for article (PubMed ID: 9636479)
1. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
Schütz E; Shipkova M; Armstrong VW; Niedmann PD; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M
Transplant Proc; 1998 Jun; 30(4):1185-7. PubMed ID: 9636479
[No Abstract] [Full Text] [Related]
2. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite.
Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Wieland E; Oellerich M
Transplant Proc; 1999; 31(1-2):1135-7. PubMed ID: 10083508
[No Abstract] [Full Text] [Related]
3. Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation.
Mourad M; Chaib-Eddour D; Malaise J; König J; Squifflet JP; Wallemacq PE
Transplant Proc; 2000 Mar; 32(2):404-6. PubMed ID: 10715456
[No Abstract] [Full Text] [Related]
4. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H
Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157
[No Abstract] [Full Text] [Related]
5. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
6. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W
Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation.
Wollenberg K; Krumme B; Pisarski P; Schollmeyer P; Kirste G
Transplant Proc; 1998 Dec; 30(8):4090-1. PubMed ID: 9865307
[No Abstract] [Full Text] [Related]
8. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
Gregoor PJ; de Sévaux RG; Hené RJ; Hesse CJ; Hilbrands LB; Vos P; van Gelder T; Hoitsma AJ; Weimar W
Transplantation; 1999 Nov; 68(10):1603-6. PubMed ID: 10589962
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation.
Brunet M; Oppenheimer F; Martorell J; Vilardell J; Carreño MC; Carrillo M; Corbella J
Transplant Proc; 1999 Sep; 31(6):2275-6. PubMed ID: 10500574
[No Abstract] [Full Text] [Related]
10. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL
Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429
[No Abstract] [Full Text] [Related]
11. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
[No Abstract] [Full Text] [Related]
12. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
[No Abstract] [Full Text] [Related]
13. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
Royer B; Davani S; Bérard M; Kantelip JP; Muret P
Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
[No Abstract] [Full Text] [Related]
16. Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation.
Zanker B; Sohr B; Eder M; Frohmann E; Land W
Transplant Proc; 1999; 31(1-2):1167. PubMed ID: 10083521
[No Abstract] [Full Text] [Related]
17. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
[TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
19. Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients.
Budde K; Braun KP; Glander P; Böhler T; Hambach P; Fritsche L; Waiser J; Mai I; Neumayer HH
Transplant Proc; 2002 Aug; 34(5):1748-50. PubMed ID: 12176561
[No Abstract] [Full Text] [Related]
20. Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients.
Schütz E; Armstrong VW; Shipkova M; Weber L; Niedmann PD; Lammersdorf T; Wiesel M; Mandelbaum A; Zimmerhackl LB; Mehls O; Tönshoff B; Oellerich M
Transplant Proc; 1998 Jun; 30(4):1182-4. PubMed ID: 9636478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
